NHC vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and VCYT
Should you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
National HealthCare vs. Its Competitors
Guardant Health (NASDAQ:GH) and National HealthCare (NYSE:NHC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.
National HealthCare has a net margin of 10.03% compared to Guardant Health's net margin of -59.05%. National HealthCare's return on equity of 6.87% beat Guardant Health's return on equity.
National HealthCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks.
Guardant Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 56.4% of National HealthCare shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 15.0% of National HealthCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Guardant Health received 302 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 71.83% of users gave Guardant Health an outperform vote.
Guardant Health currently has a consensus target price of $53.76, indicating a potential upside of 9.07%. Given Guardant Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Guardant Health is more favorable than National HealthCare.
In the previous week, Guardant Health had 17 more articles in the media than National HealthCare. MarketBeat recorded 19 mentions for Guardant Health and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.65 beat Guardant Health's score of 0.63 indicating that National HealthCare is being referred to more favorably in the news media.
Summary
National HealthCare beats Guardant Health on 10 of the 18 factors compared between the two stocks.
Get National HealthCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for NHC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National HealthCare Competitors List
Related Companies and Tools
This page (NYSE:NHC) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy NHC Stock Free NHC Stock Alerts